Tang et al. demonstrated that Bmal1 as a tumor suppressor, increases the sensitivity of tongue squamous cell carcinoma (TSCC) to paclitaxel treatment, using TSCC cell lines and xenograft mouse models (Tang et al., 2017). Here, BMAL1 is linked to neoplasm.